1 Min Read
May 2 (Reuters) - BAVARIAN NORDIC A/S:
* REG-BAVARIAN NORDIC RECEIVES FDA ORPHAN DRUG DESIGNATION FOR BN-BRACHYURY FOR THE TREATMENT OF CHORDOMA Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.